Home Compliance Pharmaceutical Manufacturer Pays $3.5 Million for Producing “Adulterated Drugs” and Connected FCA... ComplianceDOJFCANews Pharmaceutical Manufacturer Pays $3.5 Million for Producing “Adulterated Drugs” and Connected FCA Violation March 7, 2024 2 Share FacebookLinkedinTwitter Aleksandra Gigowska | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Defense Contractor Pleads Guilty to Bribery Conspiracy Worth More Than $100 Million Compliance Who Needs FEPA? Compliance DOJ Announces Pilot Program for Individual Voluntary Self-Disclosures